Latest Keytruda win, and how a “bad” second opinion about Keytruda for gastric cancer is actually a “good” thing; Update on Bob.
The News: Merck & Co.’s Keytruda may just be on its way to earlier use in head and neck cancer, an area where it once faced some questions. On Wednesday… Read more »